Pluri Management
Management criteria checks 4/4
Pluri's CEO is Yaky Yanay, appointed in Feb 2014, has a tenure of 10.75 years. total yearly compensation is $741.48K, comprised of 38% salary and 62% bonuses, including company stock and options. directly owns 4.43% of the company’s shares, worth $1.33M. The average tenure of the management team and the board of directors is 2.9 years and 3 years respectively.
Key information
Yaky Yanay
Chief executive officer
US$741.5k
Total compensation
CEO salary percentage | 38.0% |
CEO tenure | 10.8yrs |
CEO ownership | 4.4% |
Management average tenure | 2.9yrs |
Board average tenure | 3yrs |
Recent management updates
Recent updates
Pluri gains as PROTO project receives €7.5M EU grant
Sep 06Pluristem Therapeutics renames as Pluri
Jul 25Pluristem Therapeutics (NASDAQ:PSTI) Has Debt But No Earnings; Should You Worry?
Dec 04We Think Pluristem Therapeutics (NASDAQ:PSTI) Needs To Drive Business Growth Carefully
Aug 18What Is The Ownership Structure Like For Pluristem Therapeutics Inc. (NASDAQ:PSTI)?
Mar 15We're Hopeful That Pluristem Therapeutics (NASDAQ:PSTI) Will Use Its Cash Wisely
Feb 08Pluristem Therapeutics launches $30M registered direct offering
Feb 02Have Insiders Been Buying Pluristem Therapeutics Inc. (NASDAQ:PSTI) Shares?
Jan 04Pluristem expands COVID-19 program in Mexico
Dec 29Pluristem - Moment Of Truth
Dec 08Market Sentiment Around Loss-Making Pluristem Therapeutics Inc. (NASDAQ:PSTI)
Nov 30CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$22m |
Jun 30 2024 | US$741k | US$282k | -US$21m |
Mar 31 2024 | n/a | n/a | -US$22m |
Dec 31 2023 | n/a | n/a | -US$24m |
Sep 30 2023 | n/a | n/a | -US$27m |
Jun 30 2023 | US$3m | US$297k | -US$28m |
Mar 31 2023 | n/a | n/a | -US$31m |
Dec 31 2022 | n/a | n/a | -US$33m |
Sep 30 2022 | n/a | n/a | -US$36m |
Jun 30 2022 | US$1m | US$489k | -US$41m |
Mar 31 2022 | n/a | n/a | -US$47m |
Dec 31 2021 | n/a | n/a | -US$51m |
Sep 30 2021 | n/a | n/a | -US$53m |
Jun 30 2021 | US$9m | US$453k | -US$50m |
Mar 31 2021 | n/a | n/a | -US$43m |
Dec 31 2020 | n/a | n/a | -US$37m |
Sep 30 2020 | n/a | n/a | -US$31m |
Jun 30 2020 | US$350k | US$303k | -US$29m |
Mar 31 2020 | n/a | n/a | -US$29m |
Dec 31 2019 | n/a | n/a | -US$31m |
Sep 30 2019 | n/a | n/a | -US$34m |
Jun 30 2019 | US$887k | US$373k | -US$35m |
Mar 31 2019 | n/a | n/a | -US$37m |
Dec 31 2018 | n/a | n/a | -US$28m |
Sep 30 2018 | n/a | n/a | -US$28m |
Jun 30 2018 | US$443k | US$393k | -US$26m |
Compensation vs Market: Yaky's total compensation ($USD741.48K) is about average for companies of similar size in the US market ($USD646.00K).
Compensation vs Earnings: Yaky's compensation has been consistent with company performance over the past year.
CEO
Yaky Yanay (53 yo)
10.8yrs
Tenure
US$741,479
Compensation
Mr. Yaacov Yanay, also known as Yaky, is the Co-Founder of the EyeCue Vision Technologies Ltd. Mr. Yanay has been Chief Executive Officer of Pluri Inc. (formerly Pluristem Therapeutics, Inc.) since June 23...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 10.8yrs | US$741.48k | 4.43% $ 1.3m | |
Chief Financial Officer & Treasurer | less than a year | no data | 0.028% $ 8.4k | |
Chief Technology Officer | 2.9yrs | no data | no data | |
Chief Scientific Officer | no data | no data | no data | |
Chief Wellbeing Officer | no data | no data | no data | |
Chief Quality Officer | no data | no data | no data | |
Chief Business Development Officer of Pharma | no data | no data | no data | |
Chief Commercial Officer | 2.8yrs | no data | no data | |
Executive Vice President of North America | no data | no data | no data |
2.9yrs
Average Tenure
Experienced Management: PLUR's management team is considered experienced (2.9 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 9.8yrs | US$741.48k | 4.43% $ 1.3m | |
Independent Director | 3.3yrs | US$66.96k | 0.042% $ 12.7k | |
Chairman | 19yrs | US$148.17k | 2.38% $ 714.2k | |
Member of Advisory Board | less than a year | no data | no data | |
Member of Strategic Advisory Board | 2.8yrs | no data | no data | |
Member of Strategic Advisory Board | 2.8yrs | no data | no data | |
Member of Scientific Advisory Board | less than a year | no data | no data | |
Independent Director | 3.4yrs | US$63.55k | 0.047% $ 14.2k | |
Member of Scientific Advisory Board | less than a year | no data | no data | |
Independent Director | 3.4yrs | US$60.10k | 0.047% $ 14.1k |
3.0yrs
Average Tenure
70yo
Average Age
Experienced Board: PLUR's board of directors are considered experienced (3 years average tenure).